News

The trial will involve 2,600 patients with a history of chronic angina who have incomplete revascularization following percutaneous coronary intervention (PCI). Ranolazine is an extended-release tablet approved under

The Phase 3 trial includes two double-blind vehicle-controlled trials with two-to-one randomisation between Tavaborole and vehicle (the topical formulation without the active ingredient). Anacor Pharmaceuticals CEO David Perry

Vivitrol is a once-monthly, extended-release injectable naltrexone medication, used to treat alcohol dependence and opioid dependence. As measured by the number of opioid-free urine screens, Vivitrol along with

The contraceptive has received FDA approval for the prevention of pregnancy in women for up to three years. Nexplanon should be removed by the end of the third

The agreement signed in December 2009 for a period of two years, has been extended by Bristol-Myers Squibb for an additional six months term to June 2012. As

As per the agreement, both the companies will develop multi-specific products with extended half-lives, by exploiting the features of Nanobody. Ablynx will receive an upfront payment of EUR20m

The ChartAccess comprehensive EHR solution is believed to help health care centers overcome the cost, speed of implementation, and usability obstacles. Consistent, quality patient care will be enabled

Kyorin Pharmaceutical has discovered and developed Imidafenacin. Kyorin Pharmaceutical grants Daiichi Sankyo rights to activities related to the development and marketing of Imidafenacin in Brazil, as per the

A series of data points including intermediates contents, purity, quality, stability and stereochemistry were collected and compared it with the national standard of Azithromycin API that were issued